{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:26:15Z","timestamp":1778570775607,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00482-017-0207-0","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T07:58:15Z","timestamp":1494403095000},"page":"274-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Medikament\u00f6se Therapie des Fibromyalgiesyndroms","Drug therapy of fibromyalgia syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"C.","family":"Sommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Alten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-J.","family":"B\u00e4r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bernateck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Br\u00fcckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Friedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Henningsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Petzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"T\u00f6lle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"\u00dc\u00e7eyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"H\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"207_CR1","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.34390","volume":"64","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B (2012) Safety and efficacy of esreboxetine in patients with fibromyalgia: a\u00a0fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 64:2387\u20132397","journal-title":"Arthritis Rheum"},{"key":"207_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/JPR.S43395","volume":"6","author":"L Bateman","year":"2013","unstructured":"Bateman L, Palmer RH, Trugman JM, Lin Y (2013) Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a\u00a0phase IV pilot study. J\u00a0Pain Res 6:311\u2013318","journal-title":"J Pain Res"},{"key":"207_CR3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/art.1780391004","volume":"39","author":"RM Bennett","year":"1996","unstructured":"Bennett RM, De Garmo P, Clark SR (1996) A randomized, prospective, 12 month study to compare the efficacy of guaifenesin versus placebo in the management of fibromyalgia. Arthritis Rheum 39:212","journal-title":"Arthritis Rheum."},{"key":"207_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","volume":"114","author":"RM Bennett","year":"2003","unstructured":"Bennett RM, Kamin M, Karim R, Rosenthal N (2003) Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a\u00a0double-blind, randomized, placebo-controlled study. Am J Med 114:537\u2013545","journal-title":"Am J Med"},{"key":"207_CR5","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00296-012-2490-5","volume":"33","author":"B Casanueva","year":"2013","unstructured":"Casanueva B, Rodero B, Quintial C, Llorca J, Gonzalez-Gay MA (2013) Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients. Rheumatol Int 33:2665\u20132670","journal-title":"Rheumatol Int"},{"key":"207_CR6","first-page":"CD008244","volume":"10","author":"M Cording","year":"2015","unstructured":"Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ (2015) Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev 10:CD008244","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2050-6511-15-40","volume":"15","author":"SA Zanette de","year":"2014","unstructured":"de Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, Xavier F, de Souza IC, Deitos A, Torres IL, Caumo W (2014) Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a\u00a0phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol 15:40","journal-title":"BMC Pharmacol Toxicol"},{"key":"207_CR8","doi-asserted-by":"publisher","unstructured":"Draheim N, Ebinger F, Schn\u00f6bel-M\u00fcller E, Wolf B, H\u00e4user W (2017) Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren K\u00f6rperregionen und des (sog.)  Fibromyalgiesyndroms bei Kindern und Jugendlichen. Aktualisierte Leitlinie 2017. Schmerz 31. doi:\n                        10.1007\/s00482-017-0208-z","DOI":"10.1007\/s00482-017-0208-z"},{"key":"207_CR9","first-page":"898493","volume":"2013","author":"MA Fitzcharles","year":"2013","unstructured":"Fitzcharles MA, Faregh N, Ste-Marie PA, Shir Y (2013) Opioid use in fibromyalgia is associated with negative health related measures in a\u00a0prospective cohort study. Pain Res Treat 2013:898493","journal-title":"Pain Res Treat"},{"key":"207_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","volume":"30","author":"MA Fitzcharles","year":"2016","unstructured":"Fitzcharles MA, Baerwald C, Ablin J, H\u00e4user W (2016) Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials. Schmerz 30:47\u201361","journal-title":"Schmerz"},{"key":"207_CR11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22727","volume":"68","author":"MA Fitzcharles","year":"2016","unstructured":"Fitzcharles MA, Ste-Marie PA, H\u00e4user W, Clauw DJ, Jamal S, Karsh J, Landry T, Leclercq S, Mcdougall JJ, Shir Y, Shojania K, Walsh Z (2016) Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials. Arthritis Care Res (Hoboken) 68:681\u2013688","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"207_CR12","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/j.pain.0000000000000558","volume":"157","author":"I Gilron","year":"2016","unstructured":"Gilron I, Chaparro LE, Tu D, Holden RR, Milev R, Towheed T, DuMerton-Shore D, Walker S (2016) Combination of pregabalin with duloxetine for fibromyalgia: a\u00a0randomized controlled trial. Pain 157:1532\u20131540","journal-title":"Pain"},{"key":"207_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","volume":"26","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Wolfe F, T\u00f6lle T, \u00dc\u00e7eyler N, Sommer C (2012) The role of antidepressants in the management of fibromyalgia syndrome: a\u00a0systematic review and meta-analysis. CNS Drugs 26:297\u2013307","journal-title":"CNS Drugs"},{"key":"207_CR14","first-page":"78","volume":"30","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Sarzi-Puttini P, T\u00f6lle TR, Wolfe F (2012) Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. Clin Exp Rheumatol 30:78\u201387","journal-title":"Clin Exp Rheumatol"},{"key":"207_CR15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00482-012-1161-5","volume":"26","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Jung E, Erbsl\u00f6h-M\u00f6ller B, Gesmann M, K\u00fchn-Becker H, Petermann F, Langhorst J, Weiss T, Thoma R, Winkelmann A (2012) German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies. Schmerz 26:150\u2013159","journal-title":"Schmerz"},{"key":"207_CR16","first-page":"CD010292","volume":"1","author":"W H\u00e4user","year":"2013","unstructured":"H\u00e4user W, Urr\u00fatia G, Tort S, \u00dc\u00e7eyler N, Walitt B (2013) Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 1:CD010292","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00482-014-1463-x","volume":"29","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user W, Bock F, Engeser P, Hege-Scheuing G, H\u00fcppe M, Lindena G, Maier C, Norda H, Radbruch L, Sabatowski R, Sch\u00e4fer M, Schiltenwolf M, Schuler M, Sorgatz H, T\u00f6lle T, Willweber-Strumpf A, Petzke F (2015) Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz 29:109\u2013130","journal-title":"Schmerz"},{"key":"207_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-017-0209-y","author":"W H\u00e4user","year":"2017","unstructured":"H\u00e4user W, Nothacker M (2017) Methodenreport der Leitlinie 2017 zum Fibromyalgiesyndrom. Schmerz 31. doi:\n                        10.1007\/s00482-017-0209-y","journal-title":"Schmerz"},{"key":"207_CR19","first-page":"CD007115","volume":"1","author":"MP Lunn","year":"2014","unstructured":"Lunn MP, Hughes RA, Wiffen PJ (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 1:CD007115","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00296-014-2953-y","volume":"34","author":"S Mameli","year":"2014","unstructured":"Mameli S, Pisanu GM, Sardo S, Marchi A, Pili A, Carboni M, Minerba L, Trincas G, Carta MG, Melis MR, Agabio R (2014) Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int 34:1047\u20131052","journal-title":"Rheumatol Int"},{"key":"207_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pain.2010.05.029","volume":"152","author":"LB Marangell","year":"2011","unstructured":"Marangell LB, Clauw DJ, Choy E, Wang F, Shoemaker S, Bradley L, Mease P, Wohlreich MM (2011) Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 152:31\u201337","journal-title":"Pain"},{"key":"207_CR22","first-page":"CD008242","volume":"12","author":"RA Moore","year":"2012","unstructured":"Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (2012) Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 12:CD008242","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","volume":"72","author":"E N\u00fcesch","year":"2013","unstructured":"N\u00fcesch E, H\u00e4user W, Bernardy K, Barth J, J\u00fcni P (2013) Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis 72:955\u2013962","journal-title":"Ann Rheum Dis"},{"key":"207_CR24","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","volume":"155","author":"B Olivan-Blazquez","year":"2014","unstructured":"Olivan-Blazquez B, Herrera-Mercadal P, Puebla-Guedea M, Perez-Yus MC, Andres E, Fayed N, Lopez-Del-Hoyo Y, Magallon R, Roca M, Garcia-Campayo J (2014) Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6\u2011month follow-up. Pain 155:2517\u20132525","journal-title":"Pain"},{"key":"207_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AJP.0000000000000079","volume":"31","author":"X Peng","year":"2015","unstructured":"Peng X, Robinson RL, Mease P, Kroenke K, Williams DA, Chen Y, Faries D, Wohlreich M, McCarberg B, Hann D (2015) Long-term evaluation of opioid treatment in fibromyalgia. Clin J Pain 31:7\u201313","journal-title":"Clin J Pain"},{"key":"207_CR26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ejp.564","volume":"18","author":"S Perrot","year":"2014","unstructured":"Perrot S, Russell IJ (2014) More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a\u00a0meta-analysis examining six core symptoms. Eur J Pain 18:1067\u20131080","journal-title":"Eur J Pain"},{"key":"207_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00124743-200010000-00004","volume":"6","author":"IJ Russell","year":"2000","unstructured":"Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA (2000) Efficacy of tramadol in treatment of pain in fibromyalgia. J\u00a0Clin Rheumatol 6:250\u2013257","journal-title":"J Clin Rheumatol"},{"key":"207_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00482-012-1172-2","volume":"26","author":"C Sommer","year":"2012","unstructured":"Sommer C, H\u00e4user W, Alten R, Petzke F, Sp\u00e4th M, T\u00f6lle T, \u00dc\u00e7eyler N, Winkelmann A, Winter E, B\u00e4r KJ, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2012) Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline. Schmerz 26:297\u2013310","journal-title":"Schmerz"},{"key":"207_CR29","first-page":"CD009807","volume":"4","author":"S Tort","year":"2012","unstructured":"Tort S, Urr\u00fatia G, Nishishinya MB, Walitt B (2012) Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 4:CD009807","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR30","first-page":"CD010782","volume":"10","author":"N \u00dc\u00e7eyler","year":"2013","unstructured":"\u00dc\u00e7eyler N, Sommer C, Walitt B, H\u00e4user W (2013) Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev 10:CD010782","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR31","first-page":"CD011735","volume":"6","author":"B Walitt","year":"2015","unstructured":"Walitt B, Urr\u00fatia G, Nishishinya MB, Cantrell SE, H\u00e4user W (2015) Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 6:CD011735","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR32","first-page":"CD011694","volume":"7","author":"B Walitt","year":"2016","unstructured":"Walitt B, Klose P, \u00dc\u00e7eyler N, Philipps T, H\u00e4user W (2016) Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev 7:CD011694","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pain.2013.10.002","volume":"155","author":"F Wepner","year":"2014","unstructured":"Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, Hahne J, Friedrich M (2014) Effects of vitamin D on patients with fibromyalgia syndrome: a\u00a0randomized placebo-controlled trial. Pain 155:261\u2013268","journal-title":"Pain"},{"key":"207_CR34","first-page":"CD010567","volume":"11","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, Lunn MP, Hamunen K, Haanp\u00e4\u00e4 M, Kalso EA (2013) Antiepileptic drugs for neuropathic pain and fibromyalgia \u2013 an overview of Cochrane reviews. Cochrane Database Syst Rev 11:CD010567","journal-title":"Cochrane Database Syst Rev"},{"key":"207_CR35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger J, Noor N, McCue R, Mackey S (2013) Low-dose naltrexone for the treatment of fibromyalgia: findings of a\u00a0small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum 65:529\u2013538","journal-title":"Arthritis Rheum"},{"key":"207_CR36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1345\/aph.1R725","volume":"47","author":"S Yeephu","year":"2013","unstructured":"Yeephu S, Suthisisang C, Suttiruksa S, Prateepavanich P, Limampai P, Russell IJ (2013) Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a\u00a0randomized placebo-controlled pilot study. Ann Pharmacother 47:921\u2013932","journal-title":"Ann Pharmacother"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-017-0207-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-017-0207-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-017-0207-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T05:57:19Z","timestamp":1496210239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-017-0207-0"}},"subtitle":["Aktualisierte Leitlinie 2017 und \u00dcbersicht von systematischen \u00dcbersichtsarbeiten","Updated guidelines 2017 and overview of systematic review articles"],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1007\/s00482-017-0207-0","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]}}}